AJ

Asra Jabeen Quazi Azharuddin

Active Director Director DIN 10893221
DIN 10893221 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Asra Jabeen Quazi Azharuddin

Data last updated:

Asra Jabeen Quazi Azharuddin is a Director at Qsm Pharma Private Limited (since 2025).

DIN 10893221
Primary Designation Director
First Appointment 01 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Qsm Pharma Private Limited U46497MH2025PTC437400
Director01 Jan 20252025Active

Board colleagues of Asra Jabeen Quazi Azharuddin

Directorship timeline

Open interactive timeline →
Qsm Pharma Private Limited
Premium access

Shareholding and investment profile for Asra Jabeen Quazi Azharuddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asra Jabeen Quazi Azharuddin

Asra Jabeen Quazi Azharuddin currently holds 1 directorship: Qsm Pharma Private Limited (Director, since 01 Jan 2025).

Asra Jabeen Quazi Azharuddin was first appointed on 01 Jan 2025 as Director at Qsm Pharma Private Limited.

The current boards of Asra Jabeen Quazi Azharuddin's companies include Asma Parveen Abdul Azeem Maniyar (Qsm Pharma Private Limited), Masira Asiph Shaikh (Qsm Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available